{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:09:55Z","timestamp":1789150195915,"version":"build-2803163510"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder with diverse inflammatory profiles. Long-term oxygen therapy (LTOT) identifies a subgroup of patients with advanced disease; however, the systemic inflammatory characteristics of this population remain incompletely defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate systemic inflammatory markers in clinically stable COPD patients according to LTOT status and to examine whether elevated NLR reflects conventional inflammatory activation or a distinct immune profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study represents a secondary, exploratory subgroup analysis of a prospectively collected COPD cohort. Patients were stratified according to LTOT status and compared in terms of pulmonary function, gas exchange parameters, and inflammatory markers. NLR was analyzed in relation to total leukocyte count (WBC), C-reactive protein (CRP), eosinophil count, and oxygenation parameters. Between-group comparisons were performed using non-parametric tests, and correlation and multivariable regression analyses were conducted to identify independent associations with NLR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 127 clinically stable COPD patients were included, of whom 31 (24.4%) were receiving LTOT. LTOT-treated patients had significantly higher NLR values compared with non-LTOT patients (6.32\u2009\u00b1\u20094.87 vs 3.68\u2009\u00b1\u20092.41, p\u2009=\u20090.001), accompanied by lower lymphocyte and eosinophil counts. In contrast, total leukocyte count and CRP levels were similar between groups. In multivariable analysis, WBC, eosinophil count, and CRP remained independently associated with NLR, whereas oxygenation parameters and pulmonary function measures were not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests that NLR elevation in advanced COPD may not necessarily reflect overt systemic inflammation, but rather a distinct immune phenotype. Context-specific interpretation of NLR may therefore be required in advanced disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0357923","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:37:25Z","timestamp":1789148245000},"page":"e0357923","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory discordance phenotype in COPD: Dissociation between neutrophil-to-lymphocyte ratio and conventional markers"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7205-509X","authenticated-orcid":true,"given":"Can","family":"Colakoglu","sequence":"first","affiliation":[{"name":"Sivas Cumhuriyet University Faculty of Medicine","place":["Sivas, T\u00fcrkiye"],"department":["Department of Pulmonary Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sefa Levent","family":"Ozsahin","sequence":"additional","affiliation":[{"name":"Sivas Cumhuriyet University Faculty of Medicine","place":["Sivas, T\u00fcrkiye"],"department":["Department of Pulmonary Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"1","key":"pone.0357923.ref001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"PJ Barnes","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"pone.0357923.ref002","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"A Agusti","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"pone.0357923.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037483","article-title":"Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype","volume":"7","author":"A Agust\u00ed","year":"2012","journal-title":"PLoS One"},{"key":"pone.0357923.ref004","article-title":"British thoracic society guidelines for home oxygen use in adults","author":"M Hardinge","year":"2015","journal-title":"Thorax"},{"issue":"13","key":"pone.0357923.ref005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra1900500","article-title":"Update on clinical aspects of chronic obstructive pulmonary disease","volume":"381","author":"BR Celli","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0357923.ref006","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1164\/rccm.201206-1113OC","article-title":"Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease","volume":"186","author":"M Thomsen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"9589","key":"pone.0357923.ref007","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(07)61383-X","article-title":"From COPD to chronic systemic inflammatory syndrome?","volume":"370","author":"LM Fabbri","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"pone.0357923.ref008","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1183\/09031936.06.00109605","article-title":"C-reactive protein levels and clinically important predictive outcomes in stable COPD patients","volume":"27","author":"JP de Torres","year":"2006","journal-title":"Eur Respir J"},{"issue":"8","key":"pone.0357923.ref009","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12984","article-title":"The neutrophil-to-lymphocyte ratio as a marker of chronic obstructive pulmonary disease and its exacerbations: a systematic review and meta-analysis","volume":"48","author":"P Paliogiannis","year":"2018","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"pone.0357923.ref010","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s10753-013-9749-1","article-title":"Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study","volume":"37","author":"E G\u00fcnay","year":"2014","journal-title":"Inflammation"},{"key":"pone.0357923.ref011","first-page":"76","article-title":"Usefulness of neutrophil-to-lymphocyte ratio in patients with chronic obstructive pulmonary disease: a retrospective study","volume":"16","author":"SJ Lee","year":"2016","journal-title":"BMC Pulm Med"},{"key":"pone.0357923.ref012","first-page":"1937","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"12","author":"X Zeng","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"10","key":"pone.0357923.ref013","first-page":"1329","article-title":"Neutrophil\/lymphocyte ratio predicts outcome in chronic obstructive pulmonary disease patients","volume":"61","author":"HY Fang","year":"2016","journal-title":"Respir Care"},{"key":"pone.0357923.ref014","first-page":"2725","article-title":"Neutrophil-to-lymphocyte ratio as a marker of inflammatory phenotypes in chronic obstructive pulmonary disease","volume":"13","author":"E Aksoy","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"7","key":"pone.0357923.ref015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"HK Eltzschig","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0357923.ref016","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00424-005-1413-7","article-title":"Hypoxia-responsive transcription factors","volume":"450","author":"EP Cummins","year":"2005","journal-title":"Pflugers Arch"},{"issue":"1","key":"pone.0357923.ref017","first-page":"5","article-title":"Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill","volume":"102","author":"R Zahorec","year":"2001","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"pone.0357923.ref018","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13104-016-2335-5","article-title":"What is the normal value of the neutrophil-to-lymphocyte ratio?","volume":"10","author":"P Forget","year":"2017","journal-title":"BMC Res Notes"},{"issue":"3","key":"pone.0357923.ref019","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"GL Semenza","year":"2012","journal-title":"Cell"},{"issue":"1","key":"pone.0357923.ref020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.20040624","article-title":"Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity","volume":"201","author":"SR Walmsley","year":"2005","journal-title":"J Exp Med"},{"issue":"5","key":"pone.0357923.ref021","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"EV Dang","year":"2011","journal-title":"Cell"},{"issue":"11","key":"pone.0357923.ref022","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.4049\/jimmunol.1500150","article-title":"Hypercapnia inhibits autophagy and bacterial killing in human macrophages by increasing expression of Bcl-2 and Bcl-xL","volume":"194","author":"SM Casalino-Matsuda","year":"2015","journal-title":"J Immunol"},{"issue":"16","key":"pone.0357923.ref023","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"T Rhen","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0357923.ref024","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1183\/09031936.06.00053805","article-title":"Oxidative stress and redox regulation of lung inflammation in COPD","volume":"28","author":"I Rahman","year":"2006","journal-title":"Eur Respir J"},{"issue":"10082","key":"pone.0357923.ref025","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(17)31222-9","article-title":"Chronic obstructive pulmonary disease","volume":"389","author":"KF Rabe","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"pone.0357923.ref026","doi-asserted-by":"crossref","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019","volume":"53","author":"D Singh","year":"2019","journal-title":"Eur Respir J"},{"issue":"5","key":"pone.0357923.ref027","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/thoraxjnl-2013-203601","article-title":"Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema","volume":"69","author":"PJ Castaldi","year":"2014","journal-title":"Thorax"},{"issue":"7","key":"pone.0357923.ref028","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/thoraxjnl-2012-202646","article-title":"Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?","volume":"68","author":"VM McDonald","year":"2013","journal-title":"Thorax"},{"issue":"3","key":"pone.0357923.ref029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thx.2005.041822","article-title":"COPD exacerbations. 2: aetiology","volume":"61","author":"E Sapey","year":"2006","journal-title":"Thorax"},{"issue":"8","key":"pone.0357923.ref030","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201309-1634ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation","volume":"188","author":"MA Spruit","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"pone.0357923.ref031","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/thorax.58.4.294","article-title":"Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD","volume":"58","author":"WA Biernacki","year":"2003","journal-title":"Thorax"},{"issue":"9","key":"pone.0357923.ref032","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/rccm.201405-0992OC","article-title":"CXCR2 antagonist MK-7123 in patients with chronic obstructive pulmonary disease: a phase 2 randomized trial","volume":"191","author":"SI Rennard","year":"2015","journal-title":"Am J Respir Crit Care Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:37:32Z","timestamp":1789148252000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357923"}},"subtitle":[],"editor":[{"given":"Chiara","family":"Lazzeri","sequence":"first","affiliation":[{"name":"Azienda Ospedaliero Universitaria Careggi","place":["ITALY"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0357923","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}